4-146867584-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_031956.4(TTC29):c.800-1G>A variant causes a splice acceptor change. The variant allele was found at a frequency of 0.000371 in 1,463,458 control chromosomes in the GnomAD database, including 1 homozygotes. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (no stars).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 1 hom. )
Consequence
TTC29
NM_031956.4 splice_acceptor
NM_031956.4 splice_acceptor
Scores
3
3
1
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 5, offset of 1, new splice context is: ttttacatcttcacttcaAGaag. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-146867584-C-T is Pathogenic according to our data. Variant chr4-146867584-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3350480.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC29 | NM_031956.4 | c.800-1G>A | splice_acceptor_variant | ENST00000325106.9 | NP_114162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC29 | ENST00000325106.9 | c.800-1G>A | splice_acceptor_variant | 1 | NM_031956.4 | ENSP00000316740 | P4 | |||
TTC29 | ENST00000508306.5 | c.800-1G>A | splice_acceptor_variant, NMD_transcript_variant | 1 | ENSP00000422648 | |||||
TTC29 | ENST00000504425.5 | c.800-1G>A | splice_acceptor_variant | 5 | ENSP00000425778 | A1 | ||||
TTC29 | ENST00000513335.5 | c.878-1G>A | splice_acceptor_variant | 2 | ENSP00000423505 |
Frequencies
GnomAD3 genomes AF: 0.000257 AC: 39AN: 152006Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
39
AN:
152006
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000173 AC: 25AN: 144322Hom.: 0 AF XY: 0.000143 AC XY: 11AN XY: 77150
GnomAD3 exomes
AF:
AC:
25
AN:
144322
Hom.:
AF XY:
AC XY:
11
AN XY:
77150
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000384 AC: 504AN: 1311334Hom.: 1 Cov.: 21 AF XY: 0.000352 AC XY: 229AN XY: 650012
GnomAD4 exome
AF:
AC:
504
AN:
1311334
Hom.:
Cov.:
21
AF XY:
AC XY:
229
AN XY:
650012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74372
GnomAD4 genome
AF:
AC:
39
AN:
152124
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
13
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TTC29-related condition Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 29, 2024 | The TTC29 c.878-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.043% of alleles in individuals of Latino descent in gnomAD. Variants that disrupt the consensus splice acceptor site in TTC29 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
D;D;D;D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
DS_AL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at